Levosimendan in outpatients with advanced heart failure: single-center experience of 200 intermitent perfusions
EUROPEAN JOURNAL OF HEART FAILURE(2022)
摘要
Repeated levosimendan administration in advanced HF patients is a safe procedure and was associated with a reduction in HF hospitalizations, functional and LVEF improvement, and reduction in NT-proBNP levels during follow-up.
更多查看译文
关键词
Advanced heart failure,Heart transplantation,Hospital de dia,Insuficiência cardíaca avançada,Levosimendan,Outpatient treatment,Qualidade de vida,Quality of life,Transplante cardíaco
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要